Track: CME Session
Stephanie Berg, DO
Dana-Farber Cancer Institute
Needham, MA, United States
Disclosure(s): No financial relationships to disclose
Laurence Albiges, MD, PhD
Institut Gustave Roussy
VILLEJUIF, Ile-de-France, France
Disclosure(s): Advisory or Consulting or Honoraria, (all paid to Institution): Astellas – BMS – Ipsen – Janssen – Merck - MSD – Novartis - Pfizer – EISAI – Roche (Ongoing)
Arpita Desai, MD
University of California San Francisco
UCSF, California, United States
Disclosure(s): Contract Research: Merck (Ongoing)
Participated in Advisory board on 7/12/23: Exelixis (Terminated, July 12, 2023)
Participated in Advisory board on 7/20/22: Merck (Terminated, July 20, 2022)
Daniel Shapiro, MD
University of Wisconsin-Madison
Disclosure(s): No financial relationships to disclose
Hong Truong, MD
Penn State University College of Medicine
Penn State University College of Medicine, Pennsylvania, United States
Disclosure(s): No financial relationships to disclose
Moderator: Stephanie A. Berg, DO – Dana-Farber Cancer Institute
Panelist: Arpita Desai, MD – University of California San Francisco
Panelist: Daniel Shapiro, MD – University of Wisconsin-Madison
Panelist: Hong Truong, MD – Penn State University College of Medicine
Panelist: Laurence Albiges, MD, PhD – Institut Gustave Roussy
Panelist: Dena Battle – KCCure